100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
CNSC exam with correct answers R334,99   Add to cart

Exam (elaborations)

CNSC exam with correct answers

 4 views  0 purchase
  • Course
  • CNSC
  • Institution
  • CNSC

CNSC exam with correct answers

Preview 4 out of 115  pages

  • August 31, 2024
  • 115
  • 2024/2025
  • Exam (elaborations)
  • Questions & answers
  • CNSC
  • CNSC
avatar-seller
CNSC exam with correct answers

NGT |size |- |ANSWERS✔✔ |8 |- |16 |french

36 |inches



Nasoenteric |tube |size |- |ANSWERS✔✔ |8 |- |12 |french

Duodenal: |43 |inches

Jejunal: |60 |inches



Gastrostomy |tube |size |- |ANSWERS✔✔ |12 |- |28 |french



G-J |tube |size |- |ANSWERS✔✔ |6 |- |12 |french



Most |common |complication |s/p |enterostomy |tube |placement |- |ANSWERS✔✔ |peristomal |
infection



Buried |bumper |syndrome |- |ANSWERS✔✔ |results |from |growth |of |gastric |mucosa |over |the |
internal |bumper

risk |factors: |excessive |tension |between |internal/external |bumpers, |poor |wound |healing, |
significant |weight |gain



Decreasing |risk |of |aspiration |PNA |- |ANSWERS✔✔ |recent |data |suggests |jejunal |feeding |may |
be |associated |with |decreased |risk |of |asp |PNA



Diarrhea |- |ANSWERS✔✔ |>500mL |stool/24hr |(weigh |stool |= |1gm/1mL) |or |>3 |stools |for |at |
least |2 |consecutive |days

,Drug-induced |diarrhea |- |ANSWERS✔✔ |magnesium, |sorbital, |PPI, |prokinetics, |ABX



Hang |time |for |reconstituted |formula |- |ANSWERS✔✔ |4hr



Hang |time |for |prepared |formulas |- |ANSWERS✔✔ |depends |on |manufacturer; |generally |4-
12hr



Dehydration |- |ANSWERS✔✔ |dry |mouth, |dry |tongue, |thirst, |light-headedness, |HA, |fatigue, |
loss |of |appetite, |flushed |skin |, |dark |urine, |orthostatic |hypotension, |elevated |HR, |poor |skin |
turgor, |sunken |eyes, |muscle |cramps, |delirium, |elevated |BUN |(BUN:Cr |ratio |>20:1)(note: |
protein |intake, |renal |function, |muscle |mass |can |affect |this |ratio), |elevated |plasma |osmolality



Normal |urine |output |- |ANSWERS✔✔ |Minimum |output |~700mL/d

Typical |range |0.5 |- |2 |mL/kg/hr



Hepatic |steatosis |- |ANSWERS✔✔ |Hepatic |steatosis |generally |occurs |in |adults |and |presents |
with |mild |elevations |in |aminotransferases, |serum |alkaline |phosphatase, |and |bilirubin |
concentrations. |This |particular |type |of |hepatobiliary |disorder |is |most |often |a |complication |of |
overfeeding.



Cholestasis |- |ANSWERS✔✔ |Cholestasis, |occurring |primarily |in |children, |is |characterized |by |
impaired |biliary |secretion. |Elevated |conjugated |bilirubin |levels |are |the |most |common |
laboratory |manifestation |in |this |population. |



Elevations |of |alkaline |phosphatase, |gamma |glutamyltransferase |and |conjugated |(direct) |
bilirubin |most |likely |represent |cholestasis |or |biliary |obstruction. |Elevated |serum |conjugated |
bilirubin, |typically |defined |as |>2 |mg/dL, |is |considered |a |prime |indicator |of |cholestasis



Gallbladder |sludge |- |ANSWERS✔✔ |Gallbladder |sludging |or |stones |is |thought |to |result |from |
the |lack |of |enteral |stimulation |in |the |GI |tract |and |occurs |with |long-term |PN |use.

,Preferred |site |of |CVC |placement |in |adults |- |ANSWERS✔✔ |subclavian



Mural |thrombus |- |ANSWERS✔✔ |develops |when |fibrin |builds |up |inside |the |vein |which |may |
cause |the |vascular |access |device |to |adhere |to |the |vessel |wall



Fibrin |sheath |- |ANSWERS✔✔ |The |aggregation |of |fibrin |resulting |from |the |presence |of |a |
venous |access |device |in |the |vein |often |develops |as |a |fibrin |layer |(fibrin |sheath) |that |forms |
around |the |outside |of |the |catheter



Fibrin |tail |- |ANSWERS✔✔ |In |some |cases, |the |fibrin |sheath |can |grow |over |the |tip |of |the |
catheter, |or |may |accumulate |exclusively |at |the |distal |tip |of |the |catheter |creating |a |"fibrin |
tail."Cannot |aspirate



Intraluminal |thrombus |- |ANSWERS✔✔ |An |intraluminal |thrombus |occurs |as |fibrin |or |blood |
products |build |up |inside |the |catheter |lumen, |creating |a |partial |or |total |occlusion. |Cannot |
infuse |or |aspirate



Effective |solvent |for |dissolving |calcium |phosphate |- |ANSWERS✔✔ |The |use |of |0.1N |
hydrochloric |acid |has |been |reported |effective |in |clearing |catheters |with |crystalline |occlusions
|because |its |acidic |pH |is |favorable |for |calcium |and |phosphate |solubility. |Clinicians |should |be |


aware, |however, |that |direct |infusion |of |hydrochloric |acid |into |the |venous |system |can |be |
associated |with |fever, |phlebitis, |and |sepsis.



Effective |solvent |for |dissolving |lipid |residue |- |ANSWERS✔✔ |70 |percent |ethanol |is |the |most |
effective |solvent |to |dissolve |lipid |residue



Decreasing |the |risk |of |metabolic |bone |disease |- |ANSWERS✔✔ |The |most |important |
contributor |to |metabolic |bone |disease |is |a |negative |calcium |balance. |Hypocalcemia |occurs |as |
a |result |of |decreased |calcium |intake |and/or |increased |calcium |urinary |excretion. |Factors |that |
cause |hypercalciuria |include: |excessive |calcium |and |inadequate |phosphorus |
supplementation, |excessive |protein |in |PN |solutions, |cyclic |PN |infusions, |and |chronic |
metabolic |acidosis.

, Causes |of |metabolic |alkalosis |with |PN |- |ANSWERS✔✔ |An |elevated |serum |bicarbonate |level |
is |one |of |the |markers |of |metabolic |alkalosis. |Metabolic |alkalosis |may |be |caused |by |nasogastric
|suctioning, |volume |depletion |and |diuretic |use. |In |a |PN |patient, |excess |use |of |acetate, |which |is


|metabolized |to |bicarbonate, |may |precipitate |a |metabolic |alkalosis.




Causes |of |metabolic |acidosis |with |PN |- |ANSWERS✔✔ |Excess |chloride, |diarrhea |and |acute |
renal |failure |(ARF) |are |common |causes |of |metabolic |acidosis.



Normal |pH |- |ANSWERS✔✔ |7.35 |- |7.45`



Normal |PaCO2 |- |ANSWERS✔✔ |35 |- |45mmHg



Normal |serum |bicarbonate |- |ANSWERS✔✔ |23 |- |30mEq/L



Goshung |PICC |- |ANSWERS✔✔ |A |Groshong |PICC |has |a |pressure |sensitive |three-way |valve |at
|the |IV |tip |of |the |catheter |that |prevents |reflux |of |blood |into |the |catheter |which |should |


decrease |the |risk |of |occlusion. |Since |blood |cannot |reflux |into |the |catheter, |the |Groshong |
catheter |need |only |be |flushed |with |saline. |Flushing |with |heparin |is |not |necessary |to |maintain
|patency. |Although |additional |features |of |Groshong |catheters |include |soft |medical |grade |


tubing, |presence |of |antimicrobial |cuff |and |large |lumen |size, |none |of |these |contribute |to |a |
decreased |incidence |of |catheter |occlusion. |Groshong |catheters |are |not |coated |with |heparin.



Treatment |for |CVAD |occlusion |- |ANSWERS✔✔ |Alteplase |is |the |only |FDA-approved |
thrombolytic |agent |for |CVAD |occlusions.



Management |of |catheter |exit |site |infection |- |ANSWERS✔✔ |Management |of |catheter |exit |site |
infection |includes |culture |of |any |drainage |from |the |catheter |exit |site |in |addition |to |blood |
cultures.Topical |antimicrobial |agent |can |be |used |if |there |is |no |purulence |from |the |catheter |
exit |site |and |no |clinical |signs |of |sepsis. |Systemic |antimicrobial |treatment |is |used |in |the |
presence |of |purulent |drainage |from |the |catheter |exit |site |or |if |topical |treatment |is |

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through EFT, credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying this summary from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller Fordenken. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy this summary for R334,99. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

75759 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy summaries for 14 years now

Start selling
R334,99
  • (0)
  Buy now